Actium Biosystems is categorized under Electromedical Equipment in Houston, TX and active since 2010.
Actium Biosystems was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Electromedical Equipment business, which does work in the B2B market, and is classified as a Electromedical Equipment, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact George Kauss at the company’s single location by writing to 11777 Katy Freeway # 120s, Houston, Texas TX 77079 or by phoning (832) 379-4222. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Actium Biosystems |
| Contact Person: | George Kauss |
| Address: | 11777 Katy Freeway # 120s, Houston, Texas 77079 |
| Phone Number: | (832) 379-4222 |
| Website Address: | actiumbiosystems.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Electromedical Equipment |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Actium Biosystems was started in 2010 to provide professional Electromedical Equipment under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact George Kauss for inquiries that concern Actium Biosystems by calling the company number (832) 379-4222, as your correspondence is most welcome. Additionally, the physical location of the single location of Actium Biosystems can be found at the coordinates 29.784063,-95.593876 as well as the street address 11777 Katy Freeway # 120s in Houston, Texas 77079.
For its online presence, you may visit Actium Biosystems’s website at actiumbiosystems.com and engage with its social media outlets through on Twitter and on Facebook.